There has been continual interest in what the UK’s Health Technology Assessment (HTA) agency, the National Institute for Health and Care Excellence (NICE), has said when it comes to cancer
As figures show the UK continues to lag behind other developed countries in cancer survival, a new project aims to create a national database with ambitious goals to challenge the variation
Between genomic data, electronic health records and digital health tools, we have all the information we need to transform the fortunes of people living with cancer – but how do we ensure i
The FDA thinks German Merck could have a breakthrough in its hands with a new lung cancer drug that targets aggressive tumours with a mutation known as MET.
An investigational lung cancer drug from Novartis and Incyte could be on the market midway through next year after the FDA agreed to expedite development and review in a tough to treat form